Mike Collins

Mike Collins is a knowledgeable scientist with extensive experience in translational research and oncology. Currently serving as Principal Scientist at Foghorn Therapeutics Inc. since January 2021, Mike has advanced from a Senior Scientist role within the same company. Prior experience includes a significant tenure as a Graduate Student at Tufts University from September 2015 to November 2020, where Mike earned a Ph.D. in Cell, Molecular, and Developmental Biology. Earlier positions include Associate Scientist at AstraZeneca, Research Technician at Brigham and Women's Hospital, and Research Assistant at Syracuse University, where Mike obtained a B.S. in Biology in 2008.